Instead, we observed that the treatment of Mφs with 5 μg/mL CU-LNA-SLNs alone was sufficient to induce a dramatic decrease in IL-6 (70.7% inhibition, as compared to the control, p < 0.05), a cytokine found particularly increased in serum and skin lesions of patients with psoriasis [77,78]. Here, IL6 is linked to psoriasis.